New effort aims to speed the development of rare-disease treatments
The Chan Zuckerberg Biohub is launching a new funding initiative to accelerate rare-disease treatments by supporting patient-led organizations and scientists. The effort aims to build research networks, collect data, establish registries, and foster collaboration between patients, physicians, and researchers to overcome challenges in developing therapies for overlooked conditions.
Mentioned
Related Signal
Adjacent reporting
- Chan Zuckerberg Initiative's Biohub to open new rare disease funding round
- STAT+: Astellas treatment offers new hope to a devastated rare disease community
- Personalized CRISPR therapies could soon reach thousands — here’s how
- ORDI honours rare disease champions at Rare Star Awards 2026
- A.P. to strengthen care for rare disease patients, says Health Minister
- Rare disease families find roadmap to drug development at bootcamps